{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:58:17Z","timestamp":1791309497617,"version":"4.3.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2016YFD0501000"],"award-info":[{"award-number":["2016YFD0501000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bbrc.2018.01.108","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T18:48:42Z","timestamp":1517597322000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An enhanced anti-tumor effect of apoptin-cecropin B on human hepatoma cells by using bacterial magnetic particle gene delivery system"],"prefix":"10.1016","volume":"496","author":[{"given":"Xi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-gui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-shuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.01.108_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.01.108_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nbt.1769","article-title":"Gene therapy finds its niche","volume":"29","author":"Sheridan","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012-an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.bbrc.2018.01.108_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/rmv.1762","article-title":"Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them","volume":"23","author":"Hareendran","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1566523213666131223130024","article-title":"Viral hybrid-vectors for delivery of autonomous replicons","volume":"14","author":"Zhang","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.bbrc.2018.01.108_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2018.01.108_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/1568026614666140118203128","article-title":"Cationic lipids as transfecting agents of DNA in gene therapy","volume":"14","author":"Junquera","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2018.01.108_bib8","doi-asserted-by":"crossref","first-page":"30675","DOI":"10.18632\/oncotarget.5169","article-title":"Progresses towards safe and efficient gene therapy vectors","volume":"6","author":"Chira","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.01.108_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.01.108_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.170679","article-title":"Magnetotactic bacteria","volume":"190","author":"Blakemore","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.01.108_bib11","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1021\/cr078258w","article-title":"Magnetotactic bacteria and magnetosomes","volume":"108","author":"Faivre","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbrc.2018.01.108_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jgm.1068","article-title":"Bacterial magnetic particles (BMPs)-PEI as a novel and efficient non-viral gene delivery system","volume":"9","author":"Li","year":"2007","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.bbrc.2018.01.108_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/gt.2011.197","article-title":"Bacterial magnetic particles as a novel and efficient gene vaccine delivery system","volume":"19","author":"Tang","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbrc.2018.01.108_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/10717544.2017.1293195","article-title":"Bacterial magnetic particles improve testes-mediated transgene efficiency in mice","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbrc.2018.01.108_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12010-015-1567-5","article-title":"Apoptin as a potential viral gene oncotherapeutic agent","volume":"176","author":"Singh","year":"2015","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2018.01.108_bib17","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1158\/0008-5472.CAN-04-1438","article-title":"Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid acid Peptidepeptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion","volume":"64","author":"Papo","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2018.01.108_bib18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4014\/jmb.1209.09076","article-title":"Potentiation of Apoptinapoptin-induced apoptosis by Cecropin cecropin B-like antibacterial peptide ABPs1 in human HeLa cervical cancer cell lines is associated with membrane pore formation and caspase-3 activation","volume":"24","author":"Birame","year":"2014","journal-title":"J.\u00a0Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1742-7843.2006.00016.x","article-title":"Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells","volume":"100","author":"Olijslagers","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tibtech.2007.02.002","article-title":"Molecular analysis of magnetotactic bacteria and development of functional bacterial magnetic particles for nano-biotechnology","volume":"25","author":"Matsunaga","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1472-765X.2007.02143.x","article-title":"Purified and sterilized magnetosomes from Magnetospirillum gryphiswaldense MSR-1 were not toxic to mouse fibroblasts in\u00a0vitro","volume":"45","author":"Li","year":"2007","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.bbrc.2018.01.108_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/138920010791110827","article-title":"Nanoparticles for tumor targeted therapies and their pharmacokinetics","volume":"11","author":"Wang","year":"2010","journal-title":"Curr. Drug Metabol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18301232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18301232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T23:03:04Z","timestamp":1719788584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18301232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0006291X18301232"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.108","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An enhanced anti-tumor effect of apoptin-cecropin B on human hepatoma cells by using bacterial magnetic particle gene delivery system","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}